Uses

Used to reduce the duration of neutropenia and infection risk in patients receiving myelosuppressive chemotherapy and other approved indications.

Do not use if

Contraindicated in patients with a history of serious allergic reactions to filgrastim or pegfilgrastim products.

May cause bone pain, fever, headache, leukocytosis, and injection-site reactions.

Monitor for splenic enlargement, splenic rupture, respiratory complications, and severe allergic reactions.

Filgrastim is a recombinant granulocyte colony-stimulating factor that stimulates neutrophil production.

Store refrigerated at 2–8°C. Protect from light and do not freeze.